The Rising Threat of Antimicrobial Resistance in Respiratory Tract Infections in Bangladesh
Abstract
Background: Respiratory tract infections (RTIs) contribute substantially to morbidity and healthcare burden in
Bangladesh, where overcrowding, high antibiotic misuse, and limited diagnostic capacity accelerate the emergence of
antimicrobial resistance. Despite this, local data on pathogen distribution and resistance patterns remain limited. To address
this gap, this study investigates the bacterial profile and antimicrobial resistance patterns in sputum samples from patients
with suspected RTs
Materials and Methods: A retrospective cross-sectional study was conducted at Mount Adora Hospital, Sylhet,
Bangladesh, from July 2023 to February 2024. A total of 342 sputum samples were collected, and sample quality was
assessed using the Bartlett scoring system. Only culture-positive specimens with Bartlett score 1 were included. Bacterial
identification was performed using standard microbiological techniques, and antimicrobial susceptibility testing (AST)
was conducted by the Kirby Bauer disk diffusion method following Clinical and Laboratory Standards Institute (CLS)
Results: Out of 342 sputum samples, 259 (76%) acceptable-quality specimens were analyzed. Gram-negative bacteria
predominated (61%), with Klebsiella pneumoniae (41.7%) being the most frequent isolate, Among gram-positives,
Streptococcus pneumoniae (23.6%) was common. Gram-negative isolates showed highest resistance to azithromycin
(80.1%) and cefixime (79.9%). Gram-positive isolates exhibited high resistance to cefixime (80.2%) and azithromycin
(80.2%).
Conclusion: A high level of resistance to commonly used antibiotics was observed, indicating a growing threat of
antimicrobial resistance. Continuous surveillance, rational antibiotic use, and implementation of antibiotic awareness
programs are essential to combat resistant pathogens.
Keywords
Antimicrobial resistance
Respiratory tract infection
Sputum
Bangladesh.
Introduction
Lower respiratory tract infections (LRTIs) are a major
cause of global morbidity and mortality, responsible
for approximately 2.74 million deaths each year.
They account for nearly 4.4% of hospital admissions
for severe illness worldwide’ The primary bacterial
pathogens implicated in LRTIs vary geographically
but commonly include Gram-positive cocci such as
Streptococcus pneumoniae and Staphylococcus
aureus, as well as Gram-negative bacilli like Klebsiella pneumoniae, Pseudomonas aeruginosa, Haemophilus
influenzae, and Acinetobacter baumannii. A
five-year hospital-based surveillance from Maly
identified A. baumannii (18.6%), S. aureus (15.2%), P.
aeruginosa (14.2%), and K. pneumoniae (10.9%) as
the leading LRTI pathogens, with 72.5% of isolates
being Gram-negative.